News

For more than a century T&C has been doling out the kind of beauty secrets that eventually become beauty gospel. Now we’re doubling down.
The beauty member's club has a seriously strong following – but is it really worth signing up? As long-time users, we have some ...
A systematic review concluded that topical tretinoin improves photoaging despite causing irritation; it is considered the primary drug for the treatment of ... another study was published on the ...
Instead of going to treatment, the 19-year-old wanted to proceed with a criminal trial. No matter that he could get two years in prison and then be deported. Angel is not alone. A 2019 national survey ...
Optimized treatment can reduce the mortality risk for chronic heart failure (HF) by as much as 60%. The role of appropriate drug combinations and rapid diagnosis was discussed at the 91st Annual ...
Teens suffering from anxiety, panic attacks and trauma have a new, drug-free option for addressing their mental health. The Seattle-area company Freespira announced that it received U.S. Food and ...
GSK is further planning to develop the drug for potential treatment of alcohol-related liver disease (ALD). SLD affects about 5% of the global population, ALD affects about 26 million patients ...
May 16, 2025 – The FDA has granted fast-track approval to a first-of-its-kind treatment for a type of ... of a class of medicines called antibody-drug conjugates (ADCs), which are designed ...
much less start treatment. The White House did not respond to requests for comment. The budget itself says that ending drug trafficking “starts with secure borders and a commitment to law and ...
Core products include a treatment for thrombocytopenia, TPIAO, and small molecule drug Mandi. Reporting by Kanjyik Ghosh and Mrinmay Dey in Bengaluru; Additional Reporting from Andrew Silver in ...
Drug prices have been a long-standing headache for successive US administrations. The complex system through which private insurers and state programmes buy pharmaceuticals means they pay a ...